Apple Cider Vinegar: A Comprehensive Reference
1. Identity, Nomenclature, and Natural Source
Apple cider vinegar (ACV) is commonly abbreviated as ACV and is also referred to as cider vinegar. Its dominant chemical constituent is acetic acid (systematic IUPAC name: ethanoic acid; molecular formula: CH₃COOH), a short-chain carboxylic acid responsible for vinegar's characteristic pungency and sourness. ACV is a vinegar made from cider, used in salad dressings, marinades, vinaigrettes, food preservatives, and chutneys; it is made from crushed apples and the juice squeezed from them.
Apple cider vinegar is approximately 94% water and 5% acetic acid, with 1% carbohydrates and no fat or protein. In a 100-gram reference amount, it provides 90 kilojoules (22 kcal) of energy, with negligible content of micronutrients.
1.1 Production and Fermentation
Most industrial ACV is produced by a two-stage liquid fermentation: alcoholic fermentation — the anaerobic conversion of fermentable sugars to ethanol by yeast (usually Saccharomyces cerevisiae) — followed by acetic acid fermentation, the aerobic oxidation of ethanol to acetic acid (usually by Acetobacter pasteurianus or undefined starter cultures of acetic acid bacteria).
The apple cider is inoculated with either a pure culture of acetic acid bacteria or a proportion of "mother vinegar," resulting in a secondary acetic fermentation that converts the ethanol in the cider to acetic acid, yielding apple cider vinegar. The "mother" is an undefined microbial culture left in the vinegar prior to distilling and pasteurization.
In apple cider vinegar, "the mother" is a complex structure of acids that appear to have health benefits. As with many things in nature, vinegar in its unfiltered, unadulterated, and unrefined form has a variety of benefits that are lost when it is filtered and heated. Unrefined vinegars have a murky appearance and typically contain the mother culture, while clear and pasteurized vinegars typically do not contain the mother culture and do not carry the same purported benefits.
1.2 Common Forms and Preparations
Apple cider vinegar is available commercially in several forms:
- Liquid (raw/unfiltered): The traditional form, typically containing the "mother" culture and appearing cloudy or turbid.
- Liquid (pasteurized/filtered): A clear, shelf-stable version from which the mother has been removed.
- Tablets and capsules: Dried, concentrated ACV in solid supplement form. These carry specific safety concerns related to esophageal contact.
- Gummies: A consumer-friendly format in which ACV is combined with other ingredients; acetic acid content may be reduced or variable.
Vinegar has historically been made with whatever sort of foods are available, and vinegars using fruits commonly available in the North Atlantic became popular in the early nineteenth century. One 1810 cookbook includes recipes for apple cider vinegar, gooseberry vinegar, and raisin vinegar.
2. Historical and Traditional Use
The history of vinegar — and of acetic fermentation more broadly — runs parallel to the history of human civilization. Recorded vinegar history starts around 5000 BC, when the Babylonians were using the fruit of the date palm to make wine and vinegar, employing it as a food and as a preserving or pickling agent. Vinegar residues have been found in ancient Egyptian urns traced to 3000 BC, and recorded vinegar history in China dates back to texts from 1200 BC.
2.1 Ancient Greece and the Hippocratic Tradition
In ancient Greece, around 400 BC, Hippocrates, the father of modern medicine, prescribed apple cider vinegar mixed with honey for a variety of ills, including coughs and colds. Hippocrates was already using vinegar as an antiseptic for coughs and colds as far back as 2500 years ago, and he also mixed vinegar with honey as a general tonic for good health.
2.2 Ancient Rome
Roman soldiers, including Julius Caesar, drank "posca" — an apple vinegar with spices — as a stimulating, invigorating, and fortifying drink. The addition of vinegar to drinking water had the additional benefit of killing any infectious agents that might have been present. On Roman tables, a bowl of vinegar called "acetabolo" was always present, where pieces of bread were dipped to cleanse the palate between courses and aid digestion.
2.3 Traditional Chinese Medicine
Vinegar was recognised in the Ming Dynasty as a cleanser for both external and internal use; for example, fish, fruit, meat, and vegetables were treated with vinegar to prevent contamination. In traditional Chinese medicine, vinegar is drunk to stop inner bleeding, to dissolve toxins, and to remedy stagnation of bowel movements.
2.4 Medieval and Early Modern Europe
From the Middle Ages until the 1700s, vinegar was used to avoid contracting the plague and, when diluted, to prevent the spread of cholera through water.
2.5 American Folk Medicine and Homesteading
Made by fermenting apple juice into hard cider and then fermenting it again into vinegar, ACV became the secret weapon of early homesteaders. Its high acidity created an inhospitable environment for bacteria, allowing fruits and vegetables to be stored safely for months. Colonists submerged their bounty in briny, vinegary baths to keep them edible through long winters, and this practice not only preserved the produce but intensified its flavors, creating tangy pickles and chutneys.
ACV was used during the Civil War and World War I as a wound antiseptic.
3. Key Constituents and Bioactive Compounds
3.1 Primary Constituent: Acetic Acid
Apple cider vinegar, which is made through a two-step fermentation process, contains 5–6% acetic acid. Acetic acid (CH₃COOH) is the principal pharmacologically active constituent. In the second fermentation step, ethanol is converted into acetic acid by acetic acid-forming bacteria (Acetobacter species), yielding cider vinegar. The acetic acid, together with the malic acid naturally present in apple juice, contributes to the sour taste of this vinegar.
3.2 Other Organic Acids
Besides acetic acid, apple cider vinegar contains other organic acids, including malic, citric, lactic, and succinic acids, which contribute to its complex flavor and potential health benefits. HPLC chromatographic analysis of apple vinegar samples has shown that citric acid (820.62–193.63 mg/100 g) and gallic acid (285.70–54.40 µg/g) were among the most abundant compounds detected.
3.3 Phenolic Compounds and Polyphenols
Apple cider vinegar is rich in amino acids, organic acids, phenolic acids, and flavonoids. Some of these compounds are associated with health benefits and contribute to antioxidant capacity, antimicrobial, and immunostimulatory activity.
The therapeutic properties and health benefits of apple vinegar are strongly linked to its phenolic compounds. In addition to their antioxidant potential, these dietary bioactive molecules play a crucial role in the antimicrobial, anti-inflammatory, anti-cancerous, and antidepressant properties of apple vinegar.
The physicochemical properties of vinegar and the contents of acetic acid and polyphenols depend on the apple cultivar used. The therapeutic properties and health benefits of apple vinegar are strongly linked to its phenolic compounds.
3.4 Volatile Aroma Compounds
Phenylethanol, octanoic acid, ethyl acetate, butyl acetate, and isoamyl alcohol are key compounds contributing to the floral aroma of apple cider vinegar. Natural cider vinegar is a complex composition; one patent analysis identified 62 volatile compounds and noted that at least 20 more were present but not yet identified.
3.5 Minerals and Vitamins
The constituents of ACV include 5% acetic acid, mother-of-vinegar enzymes, as well as potassium, magnesium, and calcium. The concentrations of water-soluble B vitamins in cider and vinegar have been found to be higher than those in apple juice, depending on the fermentation method used.
4. Established and Proposed Mechanisms of Action
4.1 Inhibition of Carbohydrate-Digesting Enzymes
A key mechanism by which acetic acid is proposed to lower postprandial glucose involves enzymatic inhibition. Acetic acid in ACV inhibits alpha-amylase and alpha-glucosidase — enzymes that digest starches — thereby reducing post-meal glucose spikes.
4.2 Modulation of Gastric Emptying
Acetic acid has been shown to slow gastric emptying and increase the feeling of satiety, helping to reduce calorie intake. The rate of gastric emptying depends on stimulation of sensors to acids found in the proximal half of the small intestine. This slowing of gastric emptying has dual implications: it may benefit glycemic control in healthy individuals but worsen outcomes in those with pre-existing gastroparesis.
4.3 Antioxidant Activity
Acetic acid and polyphenols in vinegars together provide antimicrobial and antioxidant properties. The antimicrobial and antioxidant properties are ascertained to the total phenolic contents of ACV, as confirmed by characterisation of its bioactive compounds and antioxidant activity.
4.4 Antimicrobial Mechanisms
Acetic acid has potent antimicrobial properties and has been shown to inhibit planktonic growth of biofilms in various bacterial species. It has also been shown to inhibit yeast cell growth by causing mitochondrial and ribosomal degradation leading to apoptosis.
4.5 Acetic Acid Hepatic Metabolism and Potassium Dynamics
Acetic acid in vinegar is rapidly metabolized in the liver into bicarbonate, and potassium is used by the kidneys to excrete bicarbonate from the body. This mechanism underlies the theoretical risk of potassium wasting with chronic high-dose consumption.
4.6 Anti-inflammatory Effects (Preclinical)
In vivo results showed that administration of Golden Delicious apple vinegar (10 mL/kg) to adult Wistar rats reduced carrageenan-induced inflammation by 37.50%. These findings are preclinical and have not been directly replicated in human clinical trials to date.
5. Scientific Evidence by Area of Use
5.1 Glycemic Control and Type 2 Diabetes
This is the most extensively studied area for ACV, with multiple systematic reviews and meta-analyses available.
Systematic review and meta-analysis (2023 — PubMed): PubMed, Scopus, and ISI Web of Science databases were systematically searched for clinical trials evaluating the effects of ACV on cardiometabolic syndrome risk factors. Overall, 25 clinical trials (33 arms) comprising 1,320 adults were included. ACV consumption could significantly improve the levels of fasting blood glucose (FBG) (−21.20 mg/dL; 95% CI: −32.31 to −2.21; I²: 95.8%), HbA1c (−0.91 mg/dL; 95% CI: −1.62 to −0.21; I²: 98.9%), and total cholesterol (TC) (−6.72 mg/dL; 95% CI: −12.91 to −0.53; I²: 50.8%).
GRADE-assessed meta-analysis (Frontiers in Nutrition, 2025): Diabetes mellitus is a multifactorial metabolic disorder affecting the body's ability to regulate blood sugar levels. ACV could possibly improve diabetes, though the evidence provides conflicting results. This study aimed to evaluate the effects of ACV on glycemic profile in type 2 diabetes patients by systematic review and dose-response meta-analysis. The study assessed the bias risk of included studies using Cochrane quality assessments and used GRADE (Grading of Recommendations Assessment, Development, and Evaluation) to calculate evidence certainty.
Systematic review (2021 — BMC Complementary Medicine and Therapies): No significant effect of ACV consumption was found on serum LDL-C, HDL-C, fasting insulin concentrations, or HOMA-IR in the overall analysis. Stratified analysis revealed a significant reduction of serum TC and TG in a subgroup of patients with type 2 diabetes, in those who took ≤15 mL/day of ACV, and in those who consumed ACV for more than 8 weeks, respectively. Furthermore, ACV consumption significantly decreased fasting plasma glucose (FPG) levels in a subgroup of studies that administered ACV for more than 8 weeks. ACV intake appeared to elicit an increase in FPG and HDL-C concentrations in apparently healthy participants.
Systematic review of RCTs (2025): Most studies enrolled individuals with type 2 diabetes mellitus, overweight/obesity, or dyslipidaemia. ACV supplementation (15–30 mL/day for 4–12 weeks) consistently reduced fasting blood glucose and produced modest improvements in HbA1c among diabetic participants.
Evidence strength: Positive signals exist across multiple meta-analyses for fasting blood glucose and HbA1c reductions in type 2 diabetic populations. However, the very high heterogeneity (I² values of 95–99% in some analyses) and the preponderance of small, short-duration trials with varying methodological quality significantly limit the certainty of these conclusions. Evidence provides conflicting results. GRADE-level evidence remains low to moderate.
5.2 Body Weight and Anthropometric Outcomes
Systematic review and meta-analysis of RCTs (2025): A systematic search of PubMed, Web of Science, Scopus, and CENTRAL up to March 2025 identified 10 RCTs comprising 789 participants eligible for meta-analysis. The pooled results using a random-effects model showed that daily ACV intake significantly reduced body weight (SMD: −0.39; 95% CI: −0.63, −0.15; p = 0.001; I² = 62%), BMI (SMD: −0.65; 95% CI: −1.05, −0.26; p = 0.001; I² = 83%), and waist circumference (SMD: −0.34; 95% CI: −0.67, −0.02; p = 0.04; I² = 61%). However, no significant effects were observed on other body composition parameters. Sensitivity analyses excluding high-risk-of-bias studies confirmed the robustness of ACV's effects on body weight and BMI. Subgroup analyses suggested ACV significantly improved anthropometric parameters when administered for up to 12 weeks, at a dose of 30 mL/day, and in adults who were overweight, obese, or had type 2 diabetes.
Retracted trial note: A widely circulated 2024 RCT published in BMJ Nutrition, Prevention & Health examined ACV for weight management in Lebanese adolescents. The article was subsequently retracted in September 2025 after investigators identified "improbable data characteristics and extreme effects of apple cider vinegar on weight loss." This retraction underscores the need for caution when interpreting individual ACV trials.
Evidence strength: Modest and statistically significant effects on body weight, BMI, and waist circumference have been demonstrated across pooled analyses of RCTs, primarily in overweight, obese, or type-2-diabetic adults. Effect sizes are small to moderate, heterogeneity is substantial, and the absolute magnitude of weight reduction is modest. Overall evidence is preliminary.
5.3 Lipid Profiles (Cholesterol and Triglycerides)
Research on 120 obese Lebanese students found that ACV consumption over 12 weeks significantly reduced anthropometric variables, improved blood glucose, cholesterol, and triglyceride (TG) levels. Preclinical animal studies consistently demonstrate improvements in lipid metabolism, while limited human trials suggest modest benefits, particularly in populations with obesity and type 2 diabetes.
Despite these promising findings, current evidence is constrained by small sample sizes, short intervention periods, and other methodological limitations.
Evidence strength: Reductions in total cholesterol and triglycerides have been reported in subgroup analyses, particularly in diabetic patients and those consuming ≤15 mL/day for >8 weeks. The clinical significance of these effects and their durability remain unclear. Evidence is preliminary.
5.4 Gastric Emptying and Satiety
Pilot crossover study (PMC, 2007 — 10 patients with type 1 diabetes and gastroparesis): Ten patients with type 1 diabetes and diabetic gastroparesis completed an investigator-blinded crossover trial in which gastric emptying rate (GER) was measured using standardized real-time ultrasonography. GER was calculated as the percentage change in antral cross-sectional area 15 and 90 minutes after ingestion of 300 g rice pudding and 200 mL water, with or without 30 mL apple cider vinegar. The median values of GER1 (without ACV) and GER2 (with ACV) were 27% and 17%, respectively. The effect on the rate of gastric emptying was statistically significant (p < 0.05). This study shows that vinegar affects insulin-dependent diabetes mellitus patients with diabetic gastroparesis by reducing the gastric emptying rate even further, and this might be a disadvantage regarding their glycaemic control.
Satiety effects exist but are modest: research shows ACV can increase feelings of fullness after meals, but this may be partly due to delayed gastric emptying rather than true appetite suppression.
Evidence strength: The gastric-emptying-slowing effect of ACV is mechanistically plausible and demonstrated in a small pilot study. This effect may be beneficial for glycemic control and satiety in healthy individuals but is potentially harmful in those with pre-existing gastroparesis. Human evidence is very limited (n=10 in the key study).
5.5 Antimicrobial Activity
ACV is made from an alcoholic fermentation process of a combination of apples, sugar, and yeast. Its constituents include 5% acetic acid and mother-of-vinegar enzymes, as well as potassium, magnesium, and calcium. Acetic acid has potent antimicrobial properties and has been shown to inhibit planktonic growth of biofilms. It has also been shown to inhibit yeast cell growth by causing mitochondrial and ribosomal degradation leading to apoptosis. ACV has demonstrated strong antimicrobial action against non-resistant E. coli, Candida albicans, and Staphylococcus aureus.
Results confirm the unequivocal antimicrobial activity of ACV at full-strength concentrations. However, the activity cannot be generalised: although strong antibacterial activity was observed at 25% concentrations, in terms of antifungal activity, yeasts — especially Candida — were found to be less susceptible.
Evidence strength: In vitro antimicrobial activity of ACV and its acetic acid component is well-documented. Controlled human trials of ACV as an antimicrobial agent are lacking. Existing evidence is primarily in-vitro and preclinical.
5.6 Cardiovascular Health
Preclinical animal studies consistently demonstrate improvements in lipid metabolism, glycemic control, endothelial function, and blood pressure regulation, while limited human trials suggest modest benefits, particularly in populations with obesity and type 2 diabetes.
Among humans, only a few studies have demonstrated the cardiovascular efficacy of vinegar, and these studies have several limitations.
Evidence strength: Cardiovascular effects in humans are largely extrapolated from lipid- and glycemia-related trial outcomes. No dedicated human cardiovascular outcome trials (examining myocardial infarction, stroke, or mortality) exist for ACV. Evidence is preliminary and indirect.
5.7 Gut Microbiota
Despite promising mechanisms, the direct impact of ACV on the human gut microbiome remains insufficiently characterised. Most available evidence is extrapolated from studies on dietary fibres, isolated acetic acid, or vinegar in general, rather than ACV specifically.
Evidence strength: Insufficient. No robust human RCTs specifically examining ACV's effects on gut microbiome composition and function have been published.
6. Dosage Forms and Doses Reported in Studies
The following doses reflect those reported in the cited clinical and research literature and are not recommendations:
- ACV supplementation at 15–30 mL/day for 4–12 weeks was the range used in RCTs that reported consistent reductions in fasting blood glucose and modest improvements in HbA1c.
- A significant reduction in serum total cholesterol and triglycerides was found in the subgroup receiving ≤15 mL/day of ACV.
- Subgroup analyses found that a dose of 30 mL/day, administered for up to 12 weeks, was associated with significant improvements in anthropometric parameters in overweight, obese, or type-2-diabetic adults.
- In the gastroparesis pilot study, subjects drank 30 mL apple cider vinegar in 200 mL water daily before breakfast for two weeks before each measurement.
- One reported case of adverse outcomes involved a 28-year-old woman consuming 8 ounces (approximately 240 mL) of diluted ACV daily for 6 years — a dose far exceeding those used in clinical studies.
7. Safety Considerations and Drug Interactions
7.1 Dental Enamel Erosion
ACV's acidity can erode tooth enamel, the protective shield on the outside of the teeth. Once it wears away, it cannot be recovered. The acetic acid in straight, undiluted ACV can also burn the esophagus. The American Dental Association has highlighted this risk, noting that regularly drinking apple cider vinegar can degrade tooth enamel, leading to pain and an increased risk of tooth decay and costly dental procedures.
7.2 Esophageal and Gastrointestinal Injury
Apple cider vinegar has the potential to cause esophageal (throat) burns. A review of harmful liquids accidentally swallowed by children found that acetic acid from vinegar was the most common acid that caused throat burns. One woman experienced throat burns after an apple cider vinegar tablet became lodged in her esophagus.
Apple cider vinegar is known to cause esophageal ulceration and burning, gastroparesis, and low potassium levels in some instances.
7.3 Hypokalemia and Bone Health
There is a case report, "Hypokalemia, Hyperreninemia and Osteoporosis in a Patient Ingesting Large Amounts of Cider Vinegar," that suggests ingestion may lead to potassium wasting. There is one case report of low blood potassium and bone loss attributed to large doses of ACV taken over a long period of time. A 28-year-old woman consumed 8 ounces (1 cup) of ACV diluted in water on a daily basis for 6 years; she was admitted to the hospital with low potassium levels and other abnormalities in blood chemistry. Moreover, the woman was diagnosed with osteoporosis, a condition that causes brittle bones and is rarely seen in young people.
Acetic acid in vinegar is rapidly metabolized in the liver into bicarbonate, and potassium is used by the kidneys to excrete bicarbonate from the body. Chronic use of high doses could lead to problems. There are no controlled studies on apple cider vinegar's effects on blood potassium levels and bone health at this time.
7.4 Gastroparesis Worsening
Vinegar affects insulin-dependent diabetes mellitus patients with diabetic gastroparesis by reducing the gastric emptying rate even further, and this might be a disadvantage regarding their glycaemic control. People with gastroparesis, GERD, or esophageal issues should be cautious.
7.5 Drug Interactions
Apple cider vinegar may interact with certain medications, including insulin, diuretics, and medications for high blood pressure. These interactions can lead to dangerously low potassium levels or fluctuations in blood sugar.
Apple cider vinegar may affect potassium levels, and it should not be used by individuals who already have low potassium levels (hypokalemia), as it could make the condition worse.
7.6 Tablet and Capsule-Specific Risks
If an ACV pill gets stuck in the throat or moves too slowly down the esophagus, it can cause chemical burns to the delicate tissue. There are documented case reports of individuals experiencing permanent scarring or long-term difficulty swallowing after an ACV tablet became lodged in their throat.
7.7 Skin Burns
Due to its strongly acidic nature, apple cider vinegar may also cause burns when applied to the skin.
8. Overall Evidence Summary
Apple cider vinegar has a documented history of use spanning millennia across diverse cultures, predominantly for food preservation, wound care, and general tonic purposes. Modern clinical science has begun to examine these traditional claims in controlled settings. The strongest signals emerging from the published literature — primarily meta-analyses of small to moderate RCTs — suggest modest beneficial effects on fasting blood glucose, HbA1c, total cholesterol, body weight, and BMI, particularly in individuals with type 2 diabetes and overweight or obesity.
However, multiple caveats apply uniformly across this body of evidence: preclinical animal studies consistently demonstrate improvements in lipid metabolism, glycemic control, endothelial function, and blood pressure regulation, while evidence from limited human trials is constrained by small sample sizes and short intervention durations. High statistical heterogeneity across meta-analyses reflects the diversity of ACV preparations, doses, study populations, and outcome definitions used, making synthesis difficult and firm conclusions premature.
No large-scale, long-term human RCTs with hard clinical endpoints (cardiovascular events, diabetes progression, mortality) have been conducted for ACV. The safety profile, while generally acceptable at typical dietary or study doses, includes well-documented risks at high or prolonged doses, particularly dental enamel erosion, esophageal injury, hypokalemia, and worsening of gastroparesis.
References
- Arjmandfard D et al. Effects of apple cider vinegar on glycemic control and insulin sensitivity in patients with type 2 diabetes: A GRADE-assessed systematic review and dose–response meta-analysis of controlled clinical trials. Frontiers in Nutrition, 2025. PMC11821484
- Hadi A et al. The Effects of Apple Cider Vinegar on Cardiometabolic Risk Factors: A Systematic Review and Meta-analysis of Clinical Trials. PubMed, 2023. PMID: 37608660
- Hadi A et al. The effect of apple cider vinegar on lipid profiles and glycemic parameters: a systematic review and meta-analysis of randomized clinical trials. BMC Complementary Medicine and Therapies, 2021. PMC8243436
- Effect of Apple Cider Vinegar Intake on Body Composition in Humans with Type 2 Diabetes and/or Overweight: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PMC12472926
- Halland M et al. Effect of apple cider vinegar on delayed gastric emptying in patients with type 1 diabetes mellitus: a pilot study. BMC Gastroenterology, 2007. PMC2245945
- Effect of apple cider vinegar on delayed gastric emptying in patients with type 1 diabetes mellitus: a pilot study. PubMed, 2007. PMID: 18093343
- Yagnik D et al. Antibacterial apple cider vinegar eradicates methicillin resistant Staphylococcus aureus and resistant Escherichia coli. PMC, 2021. PMC7817673
- Authenticating apple cider vinegar's home remedy claims: antibacterial, antifungal, antiviral properties and cytotoxicity aspect. PubMed, 2018. PMID: 29224370
- Exploring the Bioactive Compounds in Some Apple Vinegar Samples and Their Biological Activities. PMC, 2023. PMC10675503
- Metabolomic analysis of the effects of a mixed culture of Saccharomyces cerevisiae and Lactiplantibacillus plantarum on the physicochemical and quality characteristics of apple cider vinegar. PMC, 2023. PMC10043408
- Role of vinegar in cardiovascular health: A narrative review. PMC, 2025. PMC12709512
- Antifungal and Antibacterial Activities of Apple Vinegar of Different Cultivars. PMC, 2021. PMC8369171
- Retraction: Apple cider vinegar for weight management in Lebanese adolescents and young adults with overweight and obesity. BMJ Nutrition, Prevention & Health, September 2025. PMC12957198
- Apple cider vinegar. Wikipedia (cites primary sources)
- What Apple Cider Vinegar Can (and Can't) Do for You. Cleveland Clinic Health Essentials
- Experts provide latest science on apple cider vinegar. American Dental Association
- Viral apple cider vinegar weight loss study retracted for flawed science. ScienceDaily, October 2025
- Effects of apple cider vinegar on glycaemic control, lipid profile, and anthropometric outcomes in adults: A systematic review of randomized controlled trials. Student's Journal of Health Research Africa, 2025
Go back